Touro Scholar
College of Health & Human Services (TUN)
Publications and Research

College of Health & Human Services

2016

Medical Marijuana and Pain Management: The Physician’s Catch
22
James M. McKivigan
Touro University Nevada, jmckivig@touro.edu

Follow this and additional works at: https://touroscholar.touro.edu/chhs_pubs
Part of the Chemicals and Drugs Commons

Recommended Citation
McKivigan, J. M. (2016). Medical marijuana and pain management: The physician's catch 22. Journal of
Nursing & Healthcare, 1(2).

This Article is brought to you for free and open access by the College of Health & Human Services at Touro Scholar.
It has been accepted for inclusion in College of Health & Human Services (TUN) Publications and Research by an
authorized administrator of Touro Scholar. For more information, please contact touro.scholar@touro.edu.

Journal of Nursing & Healthcare

Review Article

Medical Marijuana and Pain Management: The Physician’s Catch 22
James M. McKivigan*
Assistant Professor, College of Health and Human Services, School
of Physical Therapy, Touro University Nevada, USA

Corresponding author

*

James McKivigan, Assistant Professor, College of Health and Human
Services, School of Physical Therapy, Touro University Nevada, USA,
Tel: (702)777-3096; E-mail: James.McKivigan@tun.touro.edu.
Submitted: 23 Nov 2016; Accepted: 12 Dec 2016; Published: 17 Dec 2016

Abstract

In this paper, concerns connected to the usage of marijuana in treating patients are extensively analyzed. It is
revealed that physicians have been in conflict with the federal government as to whether to use cannabis for
medical purposes or if they should consider prescribing other drugs. A large percentage of physicians admit that
marijuana could be an effective drug in treating patients, especially those with acute pain, nausea, AIDS, muscle
spasms, and cancer, among other ailments. However, patients and physicians are scared of the strict laws that
criminalize the use of marijuana for medical and recreational purposes. Physicians are also reluctant to discuss
the risks of marijuana, even though they might consider recommending it for treatment. The federal government
criminalized marijuana because it is highly addictive and poses a danger to the health of an individual. Although
marijuana could be incorporated into treating patients suffering from several medical complications, it is critical
to support further research that would reveal the guidelines that physicians must follow in ensuring that patients
benefit from this kind of treatment.
Medical professionals have presented substantial evidence in
support of incorporating marijuana in pain management. In
medical research, the therapeutic benefits of herbal cannabis have
been noted to be that marijuana has analgesic capabilities, and it
could be applied in the medication of patients undergoing pain,
helping them in the recovery process. Also, marijuana could be
used in relieving anxiety and can effectively treat post-traumatic
stress disorder, inflammatory bowel complication, and migraines.
Indeed, some states in the U.S. have enacted legislation that
allows marijuana to be administered for medical purposes [1].
Washington, Colorado, Alaska, and Oregon allow the use of
marijuana for recreational purposes, and voters in Nevada and
California have recently voted to permit recreational use as well.
Perceptions of the laws restricting marijuana use changed when
these states learned the medicinal value of cannabis sativa. It should
be noted that the harmful effects of marijuana smoking have been
well-documented. In fact, this is the reason it has been difficult for
all states in the U.S. to allow marijuana smoking for recreational
and medicinal purposes [2]. Nonetheless, medical practitioners
need to accept that marijuana is an effective drug that could help
patients undergoing intense pain. Furthermore, several studies
have documented the usefulness of cannabis in treating cancer
and other chronic diseases [3]. Additionally, it could be useful in
treating mania, depression, or both. However, the medical benefits
have not been comprehensively studied, except the U.S. Food and
Drug Administration (FDA).
However, the medicinal value of herbal cannabis is accepted
reluctantly in the United States. In fact, some organizations have
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been fighting against the legalization of marijuana smoking in
Colorado and Washington, stating that such moves encourage drug
abuse.
It should be noted that people who use marijuana face
stigmatization. In hospitals and rehab centers, it is evident that
marijuana addicts are struggling to fight off cannabis addiction
[4]. It is not reasonable for medical personnel to promote a drug
that would have severe effects if it is not controlled. The intriguing
question is how cannabis smoking can be regulated, considering
that it can lead to serious addiction problems. As such, society
would not embrace the idea of smoking marijuana as a pain reliever
if it has negative implications such as substance abuse and severe
mental impairment. In some instances, the use of marijuana has led
to mental impairment. However, medical research has supported
the idea that patients who use cannabis mostly experience dry
mouth and a high. It is essential to note that marijuana smoking
reduces pain, causes sleep, and keeps a patient in a happy mood.
However, this can only be possible if marijuana is administered in
the right dosage [5].
Society expects that an individual should prioritize caring for their
health and well-being. As such, people should avoid drugs that
have a negative implication for their health. Considering what has
been said about marijuana, it does not make sense for physicians to
support this drug, even though it could be essential for patients in
pain. An individual who smokes marijuana is equated to someone
who does not care about his or her well-being. Some patients
still have to question the effectiveness of cannabis as a medical
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drug, even though physicians prescribe it for helping patients with
poor sleeping patterns, bad mood, and pain [6]. For this reason,
people have been skeptical about using marijuana for medical
purposes. In fact, some states enacted laws criminalizing smoking
marijuana. This legislation is necessary to control the health of
individuals, and substantial fines and heavy sentences are issued to
people who break these regulations. This situation is the reason it
has been difficult for physicians to encourage the use of medicinal
marijuana [7].
It does not bode well with societal expectations, and it sounds
awkward that people working in hospitals should promote
marijuana smoking. Smoking marijuana has long been known as
a crime, and it is punishable in most states in the U.S. Parents in
the United States have been strict with their children, telling them
to avoid smoking marijuana [8]. As such, it becomes difficult to
convince these individuals that smoking marijuana could help them
in relieving pain. People tend to dwell on the adverse effects of the
drug, and this has been well-captured in several pieces of literature
[5].This situation is the reason why administering marijuana as a
medicinal drug is not widely supported in the United States. The
United States has instituted laws that criminalize marijuana selling,
and smoking of the drug in public is prohibited. Some states in the
United States have legalized the use of marijuana for recreational
purposes [6]. However, they require nurses in these states to
understand the laws regarding the prescription of marijuana [3].
Moreover, the United States does not support the idea of using
marijuana in managing pain among patients, especially those
in acute care settings. The organization argues that several
interventions could be better than marijuana. As such, it has
encouraged physicians to look at the alternatives available, as
opposed to prescribing marijuana to patients in intense pain.
The United States has funded several drives against drug abuse.
Marijuana is always the top drug in these movements because it
falls among drugs that youths are likely to harm.
Therefore, the aim is to discourage people from smoking
marijuana and encourage them to stay away from other drugs and
alcoholic drinks. Because of these actions, it has become difficult
for people to accept that smoking marijuana is healthy. The U.S.
government moved with urgency to institute laws to control
marijuana smoking. The move leaves physicians stranded on
whether to prescribe marijuana as a pain reliever, even though past
studies have identified the value of marijuana in controlling pain in
patients. Experts in the health sector have been reluctant to oppose
the move by the United States to oppose the use of marijuana.
In fact, the laws led to the enactment of more stringent laws in
controlling drug abuse, incorporating the usage of marijuana for
medical intervention [4].
Some patients have been skeptical concerning the proper dosage of
marijuana. It poses a difficult situation for physicians in directing
the required dosage, considering the high chances of overdosing
on marijuana, which is common in patients. Additionally, no
federal oversight of purity or content has been identified, meaning
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that people are in the dark regarding the substance of cannabis. In
fact, questions are raised because many individuals may not know
the active ingredients of marijuana, and the research has not been
clear on this topic. There have also been concerns about increased
clinical availability of herbal cannabis, which could be detrimental
to the personal health of an individual. It is dangerous for patients
who may end up fighting an addition of marijuana, especially in
convincing them that they do not have to smoke the drug after the
pain has eased. When herbal cannabis is available in pharmacies,
youths are at risk of abusing this medication. Patients may also
continue using the drug long after the pain has disappeared, leading
to additional medical complications [3]. For a drug associated with
severe medical complications, it becomes difficult to convince
people that choosing marijuana is the best choice in relieving
pain in patients. In the past, studies have noted complications
such as orthostatic hypotension. Another study strongly indicated
that people who smoke marijuana for one hour are at risk of
myocardial infarction [1]. It is thus essential for both sides to come
into agreement, providing detailed recommendations along similar
lines. For instance, the use of marijuana in relieving pain could
be effective if more funds are invested in pain-related cannabis
research [4]. Medical personnel should be involved in the research
of herbal cannabis, which is possible through the broadening of
pain conditions, as well as actively participating in increasing
pain condition research in phase-three trials. Besides, the situation
could change if regulatory restrictions, which are known to
impede research, are eliminated. In fact, researchers must consider
rescheduling the research to schedule one drug. The government
needs to consider improving access to high-quality cannabis for
research, enabling diverse strains and derivatives, making it easier
to determine cannabinoid content ratios. Importantly, states should
collect individual- and population-level data, as it would make it
simpler to understand different health outcomes, as well as the
health implications of using cannabis in pain management.
Currently, most states have not collected individual-level health
data on the usage of marijuana, including important details
uncovering how marijuana works. It also provides details on
unexpected complications, giving reasons why certain medications
have to be stopped because administering these drugs does
not have a positive impact on the health of the patient. Argues
that if medical personnel in the United States were organized
in researching marijuana, the myths surrounding the harmful
effects of marijuana would be addressed [9]. Such a study would
provide important details helping physicians to learn about the
health impacts of using marijuana. In the past, researchers have
emphasized that treatment can only be effective if there is quality
control in the production and dispensing of cannabis. This situation
is vital in ensuring that medical benefits are not compromised. As
documented by Wilkinson et al. the legalization of marijuana for
therapeutic modality requires strict quality control, with the known
constituents clearly identified. Notably, medication avenues should
be opened, providing a chance for marijuana to be dispensed by
pharmacists, in particular, those who acquire medicinal grades of
cannabis from sources with adequate quality control. Such a move
would eliminate the blurred lines that exist between therapeutic
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marijuana and recreational marijuana [4].
The government may come up with legislation that limits physicians
and patients from using marijuana for medicinal purposes. This
action is likely to interfere with the relationship between patients
and doctors. The interaction between the physician and patient
improves the quality of care accorded to the patients, as doctors
work on relieving pain in patients. In some cases, the government
may come up with legislation that guides accepted interventions,
and in some cases, the government imposes restrictions on the
medicine that could be used in treating patients [6]. It is expected
that the dose administered should not be harmful to the patient or
lead to death.
According to the law, physicians should not be involved in
activities that may cause harm to the patient. A desirable law is one
that gives the patient the ability to consent to use marijuana in their
treatment, especially when the patient deems it fit to ease the pain.
In the case of an underage patient, the parent should be allowed to
make the decision on their behalf [10]. The physician’s role is to
disclose information on marijuana treatment options, advising the
patient on the right dosage and the right time to use herbal cannabis.
Previous findings have revealed the advantages of using marijuana
in easing pain and have also pointed out the negative effects of
allowing marijuana to be used in treating patients suffering from
acute pain. Formal drug approval techniques provide physicians
with the information necessary to form an analysis, putting into
consideration the risks and benefits for a certain patient, through
examining issues such as safety and efficiency of the treatment
offered. In this respect, the biggest concern is not to prohibit
physicians from administering medicinal marijuana, but rather
controlling the treatment process to ensure that the drug is not
misused. Importantly, physicians should demonstrate a willingness
to provide the essential guidelines for this treatment to the patient
[1].
In the past, reservations have been posed as to the effectiveness
of FDA rules in controlling the application of cannabis in treating
patients. Initially, questions have been raised about the safety
measures of using marijuana in treating patients. Some scholars
have argued that the evidence provided regarding the harmful
effects of drugs is not substantial. However, the adverse effects
of marijuana have been widely discussed, at the expense of the
usefulness of this medication in treating patients [8].
The harmful effects of cannabis sativa are widely known, as
opposed to its usefulness as a medicinal drug. On this account, it
would be necessary for the FDA to evaluate the risks and benefits
of using a medication that has been marred by controversy. Indeed,
the efforts of government officials to frustrate the use of marijuana
in medical research and the treatment of patients are baffling [2].
The government should reconsider its stance because marijuana
has proven that it could be used in treating cancer patients [6].
Besides, HIV/AIDS patients could benefit from marijuana,
especially patients who have learned of their HIV status and who
find it hard to accept that they have to accept to live with the
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medical condition. Indeed, the proper use of marijuana is essential
in the medication process. Given its addictive nature, physicians
should only prescribe enough drugs to be used in treatment. It is
proposed that pharmacies should shelve medical marijuana that
contains codeine and morphine and encourage patients to use these
drugs according to prescriptions [11].
Even though 40 states have legalized the use of cannabis as
a medicinal drug, federal laws consider marijuana an illegal
substance. The federal government regulates illicit drugs through
the Controlled Substance Act (CSA). The Act does not recognize
differences between the medical and recreational use of cannabis.
Instead, individuals who possess, cultivate, or are involved in the
selling and distribution of marijuana may face prosecution for
going against the stipulations of the Act.
As documented by Goldsmith et al. marijuana is grouped under
controlled substances, which means it is similar to drugs such as
cocaine and heroin. In the United States, the federal government
classifies drugs in a schedule, and this is based on the potential
of abusing a particular drug or evaluating its medicinal value.
The CSA classifies cannabis as a Schedule 1 drug, based on the
assumption that marijuana is highly addictive and has no medicinal
value. According to federal laws, doctors should not prescribe
cannabis for medicinal use [12].
Federal cannabis laws are stringent, and individuals found in
possession of marijuana face a substantial penalty [13]. Federal
statutes refute the medicinal value of marijuana, claiming that the
drug is harmful to the health of human beings. In some previous
rulings, federal judges have insisted that medical issues should
not be cited as a defense. It should be observed that these laws
apply to the United States, meaning that these statutes cover states
such as Colorado, Washington, Oregon, and Alaska. In 2016,
federal agencies designed guidelines and other policy memoranda,
significant in managing conflicts between federal and state laws,
connected to the use of medical marijuana [11].
From 1975 to 1992, the U.S. government worked on legislation
that would make it easier for patients to use herbal cannabis in
recuperation from several medical complications. The laws
approve the use of marijuana for medical and recreational use.
However, it should be according to the Investigation New Drug
(IND) program guidelines. Eight U.S. states entered into an
agreement to legalize the use of medical cannabis, in line with
the stipulations of IND. However, few patients demonstrated
willingness to use marijuana for medical purposes. Later, after the
1970s, the Reagan administration came up with laws that would
hinder patients from using marijuana for medicinal purposes.
This action was a game-changer and led to more frustrations in
the process of accepting marijuana in hospitals. In the recent
past, the Obama administration claimed that it would not punish
individuals using marijuana in states that had legalized its use
for the recreational purpose. On this account, physicians in these
states were free to prescribe marijuana as a drug that would help
patients in their recovery processes.
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Other states in the U.S. have used medical necessity as an excuse,
in a bid to defend themselves whenever they are accused of
recommending a highly addictive drug to treat patients. Critical
medication decisions have been made based on these laws,
considering that the wellness and safety of patients are paramount.
It should be noted that patients who get marijuana from illegal
markets, without the recommendation of physicians, should be
punished [1].
In 1990, marijuana advocates pushed for a referendum that
would allow legalization of marijuana for medical purposes. This
consequence is after it was clear that the federal IND program had
failed in its mandate to control the use of cannabis for treatment. It
was necessary to work with the citizenry in implementing new laws.
Following these changes, patients had the freedom to use herbal
cannabis in managing their medical complications. In the 1966
referendum, Californians voted for using marijuana in hospital
setups and in managing pain among patients. Approximately 56%
of Californian voters were in support of the referendum. As such,
the state of California had to work with the health care department
in the state to ensure that the prescription of herbal cannabis is
safe. In this regard, patients were given the ability to use marijuana
for medication [3].
A large percentage of physicians claimed that herbal cannabis was
effective in treating patients experiencing nausea, weight loss,
pain, and muscle spasms. Furthermore, cannabis sativa would also
be used in conditions where the patient is seriously ill, and the
physician deems it fit to administer herbal cannabis. Nonetheless,
the elaboration on the suitability of this treatment was up to the
doctor to decide. This way, the doctor would advise the patient
if it was necessary to incorporate marijuana into their treatment.
Twenty-three U.S. states enacted laws to allow the medical use of
the marijuana, legislation that has been in place since 1966. Some
of the laws on the medicinal use of marijuana have been passed
through referenda, and others have been affected by legislative
acts. In California, marijuana was legalized to treat patients with
different medical complications as long as physicians do not go
against the stipulated laws. It is critical to remember that the
legislation on the use of medicinal marijuana is dissimilar across
different states. Several factors have to be considered before
marijuana is administered for therapeutic use. Some of the factors
include the type of illness, how marijuana is acquired from the
market, and how patients use the drug [1].
It is worth noting that different states have posted different results
in approving by physicians the use of marijuana. In some states,
the medicinal use of marijuana is confined to the previous statistics
on the efficacy of herbal cannabis. The legislation in some states
limits physicians in using marijuana to managing patients with
cancer aids and stimulation of appetite. Some states do not have
limitations on how the doctor uses marijuana for medical purposes.
As a result, the physician decides if the medical complication
warrants the prescription of marijuana. In some jurisdictions, the
physician is required to examine the state of the patient before
sanctioning the use of marijuana in treatment. It is probable that
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the doctor will advise the patient concerning the risks of using
marijuana in their treatment [7].
It is argued that the use of herbal cannabis in treatment should
be done in line with the stipulated guidelines. In administering
treatment, physicians should ensure that they provide empathetic
treatment to patients [9]. In other words, physicians need to choose
an intervention that is not harmful to the life of the patient. In this
respect, a procedure should be in place to limit the adverse effects
of using marijuana in managing pain among patients. There is
no concrete evidence pointing out the efficacy or risks of herbal
cannabis; it would be ideal for physicians to caution patients about
the known dangers of using herbal cannabis. The threats posed
by using marijuana have been widely discussed by scholars [10].
Most of these studies have analyzed the adverse effects of smoking
marijuana for recreational purposes. It would be crucial for patients
to consent to marijuana treatment. This action should happen after
physicians have provided comprehensive information to patients,
to enable them to understand the risks of using herbal cannabis. In
other words, the administering of herbal cannabis should be in line
with the physicians’ ethical obligations [9].
It is worth remarking that the scarcity of scientific evidence has
been a great concern for physicians, and this has led to distress to
nurses in convincing patients to accept using marijuana in their
treatment. Some medical practitioners have fears that, in prescribing
herbal cannabis, it may be difficult to control the medication, and
it could lead to their prosecution. As Kondrad and Reid point
out, it is difficult for physicians to monitor the use of marijuana
for medication, especially for patients who have to recuperate at
home and in other places far from doctors. Also, it is challenging
to control addiction problems. This situation is a great concern,
given the several health risks linked to smoking marijuana, such
as respiratory complications. Essentially, medical practitioners’
recommended therapy should be in line with sound scientific
study, through outlining the efficacy and safety of marijuana. In
this respect, before physicians support using herbal cannabis in
managing pain and other illnesses, described pharmacotherapy
standards should be met. Presently, doctors administering herbal
cannabis are yet to fulfill these requirements [7].The absence of
this crucial knowledge of effective dosing, as well as the lack of
information on the actual benefits of herbal cannabis, needs to
be investigated. On this account, proper guidelines should be set
up outlining a desirable intervention for physicians should they
recommend marijuana medication.
As Davis et al. discuss, the process can only be effective if
physicians understand their responsibility in caring for patients.
This process shows that doctors are more concerned about patients’
wellbeing. In the United States, the law stipulates that doctors have
to accept responsibility for the patients instructed to take herbal
cannabis. Some states have passed legislation that specifies the
dosing procedure, duration, and frequency of using marijuana for
medicinal purposes [10]. It is important that these form the basis of
therapy, given the fact that marijuana is a drug that could lead other
medical complications if its use is not monitored. Indeed, patients
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may not be in a position to control this medication, meaning it
is essential to work with physicians in ensuring that the adverse
effects of marijuana smoking do not interfere with treatment.
The adoption of marijuana in medication, especially in pain
management, is centered on providing the needed care to patients
[8]. It is essential to remember that, currently, the sanctioning of
herbal cannabis for therapy is done by a small percentage of medical
practitioners in the United States. For instance, in Colorado, only
15 physicians issued approximately 50% of recommendations,
which advocate the application of herbal marijuana in treating
patients in hospitals. Indeed, motives surrounding these medical
behaviors require further evaluation, considering the ethical issues
surrounding the use of marijuana for medical purposes. Recently,
it was revealed that physicians lack confidence in administering
cannabinoids [7]. Also, these physicians lack the competence
to advise patients in using herbal marijuana in treating medical
complications. In Colorado, 19% of physicians recommended
medical marijuana, whereas 92% claimed that more education is
necessary to reinforce the skills and competence of physicians.
Similar studies in Canada documented the declining confidence
in doctors, after an evaluation of their skills regarding the use of
medicinal cannabis in hospitals. As such, physicians can bolster
their confidence if they have a chance to attend a program that
aims to reinforce their knowledge and competence in incorporating
marijuana into treatment.
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